Farther Finance Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Buy |
13,079
+1,017
| +8% | +$109K | 0.03% | 473 |
|
|
2025
Q1 | $1.22M | Buy |
12,062
+1,002
| +9% | +$101K | 0.03% | 434 |
|
|
2024
Q4 | $988K | Sell |
11,060
-263
| -2% | -$23.5K | 0.04% | 374 |
|
|
2024
Q3 | $949K | Buy |
11,323
+580
| +5% | +$48.6K | 0.04% | 361 |
|
|
2024
Q2 | $821K | Buy |
10,743
+6,597
| +159% | +$504K | 0.04% | 342 |
|
|
2024
Q1 | $282K | Buy |
4,146
+351
| +9% | +$23.9K | 0.02% | 575 |
|
|
2023
Q4 | $219K | Buy |
3,795
+2,217
| +140% | +$128K | 0.02% | 527 |
|
|
2023
Q3 | $83.3K | Buy |
1,578
+306
| +24% | +$16.2K | 0.01% | 624 |
|
|
2023
Q2 | $68.8K | Buy |
1,272
+108
| +9% | +$5.84K | 0.02% | 572 |
|
|
2023
Q1 | $58.2K | Sell |
1,164
-27
| -2% | -$1.35K | 0.02% | 566 |
|
|
2022
Q4 | $55.1K | Buy |
+1,191
| New | +$55.1K | 0.02% | 464 |
|